SCHEMBL7694696

SCHEMBL7694696

CC(=O)NCC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1Oc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
ATM Q13315 1/20 0.46
ICMT O60725 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
RECQL P46063 1/20 0.45
MAPK8 P45983 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
RAB9A P51151 1/20 0.44
PPARA Q07869 1/20 0.43
ITGB1 P05556 1/20 0.42
ITGA4 P13612 1/20 0.42
ITGB7 P26010 1/20 0.42
CTSS P25774 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694147 0.89 ACE (0.46) KDM4EL3MBTL1ALDH1A1HPGDGAA
SCHEMBL7659831 0.86 KDM4E (0.48) KDM4EL3MBTL1ALDH1A1HPGDGAA
SCHEMBL7701622 0.85 L3MBTL1 (0.44) KDM4EL3MBTL1ALDH1A1HPGDGAA
SCHEMBL7701336 0.82 CASP1 (0.49) KDM4EL3MBTL1ALDH1A1HPGDGAA
SCHEMBL7698402 0.81 CHRNB2 (0.52) L3MBTL1HTTKMT2AITGB1ITGA4
SCHEMBL7690823 0.77 CAPN1 (0.60) KMT2ACTSSCTSK
SCHEMBL7666903 0.76 KDM4E (0.47) KDM4EL3MBTL1ALDH1A1HPGDGAA
SCHEMBL7696161 0.75 CTSB (0.43) L3MBTL1CTSSCTSK
SCHEMBL7787791 0.75 ROCK2 (0.51) KDM4EL3MBTL1ALDH1A1HPGDGAA
SCHEMBL7382832 0.75 ROCK2 (0.51) KDM4EL3MBTL1ALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed